- Center on Health Equity & Access
- Clinical
- Health Care Cost
- Health Care Delivery
- Insurance
- Policy
- Technology
- Value-Based Care
Tesh Khullar on Keeping Up With Practice Transformation Under Value-Based Care
Learn what works and then try to apply it to your marketplace, explained Tesh Khullar, senior vice president and advisor, Flatiron Health.
Learn what works and then try to apply it to your marketplace, explained Tesh Khullar, senior vice president & advisor, Flatiron Health
Transcript
What are some best practices trying to keep up with practice transformation under value-based care?
I think learning and coming to meetings and learning what other practices are doing. We’re at the cutting edge of value-based care. You have groups like [South Carolina Oncology Associates] in South Carolina that are doing custom deals with their payers in their marketplace. Learning what’s working for other practices and then incorporating that and having a conversation with your payer about being the lower cost provider and what you can do to help the payer lower cost, which ultimately is going to lower cost for the patients, is what practices have to do. So, learn what works and then try to apply it to your marketplace, in particular.
Impact of Amivantamab-Lazertinib on EGFR, MET Resistance Alterations in NSCLC: Danny Nguyen, MD
September 15th 2025The combination of amivantamab and lazertinib in first-line non–small cell lung cancer (NSCLC) significantly reduces resistance mechanisms with implications for second-line treatment, said Danny Nguyen, MD, of City of Hope.
Read More
Disparities in Biomarker Testing Impact Nonsquamous NSCLC Outcomes: Surbhi Singhal, MD
September 6th 2025Surbhi Singhal, MD, of the University of California Davis, discussed disparities in biomarker testing among patients diagnosed with stage IV nonsquamous non–small cell lung cancer (NSCLC).
Read More
